Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
01:35pm, Monday, 06'th May 2024
Dow Jones drug giant Merck and Nvidia stock are among the best stocks to buy and watch in today's stock market action.
PRESS RELEASE - 06/05/2024, 07:00 CEST Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region Biocartis (Mechelen, Belgium
Here's Why Merck (MRK) is a Strong Momentum Stock
10:56am, Friday, 03'rd May 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces KEYNOTE-811 Trial Met Dual Primary Endpoint as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or GEJ Cancer.
Is Merck Stock Fully Valued At $130?
06:00am, Wednesday, 01'st May 2024
Merck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The company garnered $15.8 billion in revenue and adjusted earnings of $2.07 per share, compared
Dow Earnings: How Merck, Caterpillar Shares Are Faring
02:40pm, Thursday, 25'th Apr 2024
Dow Jones Industrial Average (DJI) components Caterpillar Inc. (NYSE:CAT) and Merck & Co Inc (NYSE:MRK) are moving in opposite directions today after their respective first-quarter earnings reports, a
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
01:11pm, Thursday, 25'th Apr 2024
Merck (MRK) beats first-quarter estimates for earnings and sales. The company raises its EPS range for 2024.
Merck's Cancer Drug and Vaccine Sales Drive Better-Than-Expected Results
11:36am, Thursday, 25'th Apr 2024
Merck (MRK) shares advanced in intraday trading Thursday after the pharmaceutical firm reported better-than-expected quarterly results, and raised and narrowed its guidance on strong sales of its bloc
Merck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11:31am, Thursday, 25'th Apr 2024
Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street est
Merck jumps on profit beat as Bristol Myers Squibb slips to a loss
09:51am, Thursday, 25'th Apr 2024
Merck & Co Inc (NYSE:MRK, ETR:6MK), the pharmaceutical firm, saw its shares tick 3.5% higher after its cancer drug Keytruda helped it post a profit and sales beat. Revenues during the group's first qu
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
06:33am, Thursday, 25'th Apr 2024
Merck & Co on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda and human papillomavirus (HPV) vaccine Gardasil.
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
06:32am, Thursday, 25'th Apr 2024
The first-quarter results come as Merck shows substantial progress in preparing for Keytruda's patent expiration in 2028.
Merck's first-quarter results beat expectations amid healthy vaccine-sales growth
06:31am, Thursday, 25'th Apr 2024
Merck & Co. Inc. on Thursday reported first-quarter results that beat analysts' expectations amid strong sales of vaccines and cancer drug Keytruda.
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
01:06pm, Wednesday, 24'th Apr 2024
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline
4 Large Drug Stocks to Hold on to Amid Industry Challenges
11:11am, Wednesday, 24'th Apr 2024
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining i
